Here we go again with people trying to ban funding of embryonic stem cell research.
Yes, including according to a new article from the Catholic News Agency.
Who is trying to get this ban? Some Republicans in The U.S. Senate.
I’ve wondered for years if the Trump Administration might take action against embryonic stem cell research in part because of the views of VP Mike Pence. But for a long time nothing has happened. I don’t know if the senators mentioned in the Catholic News piece are coordinating with the Trump Administration or Pence on this bill, but it seems reasonably likely.
From the article:
“Sen. Roger Wicker (R-Miss.), the sponsor of the legislation, said that the bill, the Patients First Act, “would encourage the use of adult stem cells for medical purposes,” an “ethical and effective alternative to embryonic stem cell research.”
“Medical breakthroughs achieved via stem cell research need not come at the expense of innocent life,” Sen. Marsha Blackburn (R-Tenn.), a cosponsor of the bill, stated.
The Patients First Act would reverse President Barack Obama’s 2009 executive order that allowed for federally-funded research at NIH using embryonic stem cells.”
- “Promote the creation of pluripotent stem cell lines without the creation of human embryos, or the destruction or discarding of, or risk of injury, to human embryos;
- Intensify stem cell research that may result in an improved understanding of, or treatments for, diseases and other adverse health conditions;
- Promote research and human clinical trials using stem cells that are ethically obtained and show evidence of providing clinical benefit for human patients;
- Direct the National Institutes of Health to prioritize stem cell research that has the greatest potential for near-term clinical benefits given currently available evidence;
- Reverse President Obama’s Executive Order 13505, which gave the Department of Health and Human services the authority to use embryonic stem cells in research; and
- Codify the Dickey-Wicker Amendment prohibiting the use of federal funds for human embryonic stem cell research.”